Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery rPEGs to be part of Evonik’s specialized lipid platform Latest step in strategy to grow business in ...
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery rPEGs to be part of Evonik’s specialized lipid platform Latest step in strategy to grow business in ...
Tags: Central and East Europe,English,Europe,Germany,News,PE
Published on February 22, 2024 5:28 PM (GMT+8)SHARE THIS STORY